LONDON, June 28, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink.
Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative ...
U of Chic to use anti-CD40L monoclonal antibody to replace tacrolimus, the harsh anti-rejection drug that has caused transplant failure after initial success. This new anti-CD40L antibody has a great ...
A vascularized organoid model of hormone-secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies. “Our results highlight the importance ...
Interesting Engineering on MSN
Human fat creates organoids for bone marrow, neural tissue, and insulin secretion
The study shows that fat tissue, when processed and cultured in a specific way, can self-organize into structures resembling bone marrow, pancreatic islets, and even neural tissue. These organoids ...
These factors prompted research into better and more permanent treatments for T1D. The most obvious solution: restore the natural repertoire of β cell islets. Although most recipients experienced ...
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback